Cargando…
Surgical intervention for acute pancreatitis in the COVID-19 era
Approximately 15%-19% of patients with severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infections develop gastrointestinal symptoms. Acute pancreatitis (AP) has been reported in 0.1% of patients with coronavirus disease 2019 (COVID-19). Biliary AP was most common (78.4%) before the...
Autores principales: | Su, Yu-Jang, Chen, Tse-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649528/ https://www.ncbi.nlm.nih.gov/pubmed/36387796 http://dx.doi.org/10.12998/wjcc.v10.i31.11292 |
Ejemplares similares
-
Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations
por: Fancellu, Alessandro, et al.
Publicado: (2021) -
Liver injury in the era of COVID-19
por: Cichoż-Lach, Halina, et al.
Publicado: (2021) -
Colorectal cancer screening in the COVID-19 era
por: Kadakuntla, Anusri, et al.
Publicado: (2021) -
Recent advances in the management of autoimmune pancreatitis in the era of artificial intelligence
por: Mack, Sahar, et al.
Publicado: (2022) -
Surgical management of acute pancreatitis: Historical perspectives, challenges, and current management approaches
por: Alzerwi, Nasser
Publicado: (2023)